back
Biology

The 'recalibration phase' of AI in drug discovery

Written by
 
Shelby
Published on
 
Dec 2, 2022
0
100
Increasing the curative potential of the industry
you may also like
Biology
A Quantitative Look at Biotech Platforms
Written by
 
Mackenzie
Published on
 
Mar 25, 2026
Biology
Scaling Human Challenge Trials
Written by
 
Shelby
Published on
 
Mar 17, 2026
Compound is a Thesis-Driven, Research-Centric Investment Firm
Helping accelerate the futures that our founders believe in
pages
HomeAbout UsPortfolioWritingTheses
Social
@Compoundvc@CompoundArxiv
Contact
414 BroadwayNew York, NY 10013[email protected]
UPDATES
Subscribe for periodic updates
The latest updates from Compound, sent directly to your inbox